Select a Sector or Industry
Revenue Growth Rankings for Healthcare Sector
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Rank | Symbol | Company |
Revenue Growth
|
Pro Rating
|
|---|---|---|---|---|
| 1 | CRIS | Curis | 13944% | Go Pro |
| 2 | SOMX | Somaxon Pharmaceuticals | 9574% | Go Pro |
| 3 | PACB | Pacific Biosciences of California | 4681% | Go Pro |
| 4 | NYMX | Nymox Pharmaceutical Corporation | 3900% | Go Pro |
| 5 | IMMU | Immunomedics | 2855% | Go Pro |
| 6 | NVAX | Novavax | 2762% | Go Pro |
| 7 | PCYC | Pharmacyclics | 2659% | Go Pro |
| 8 | ARIA | ARIAD Pharmaceuticals | 1921% | Go Pro |
| 9 | OPTR | Optimer Pharmaceuticals | 1552% | Go Pro |
| 10 | TSRX | Trius Therapeutics | 1469% | Go Pro |
| 11 | BDSI | BioDelivery Sciences International | 1126% | Go Pro |
| 12 | VRTX | Vertex Pharmaceuticals | 759.75% | Go Pro |
| 13 | HALO | Halozyme Therapeutics | 575.47% | Go Pro |
| 14 | INHX | Inhibitex | 339.13% | Go Pro |
| 15 | AVNR | Avanir Pharmaceuticals | 294.00% | Go Pro |
| 16 | OMER | Omeros Corporation | 288.58% | Go Pro |
| 17 | CYTK | Cytokinetics | 262.18% | Go Pro |
| 18 | BPAX | Biosante Pharmaceuticals | 256.34% | Go Pro |
| 19 | PSDV | pSivida | 246.64% | Go Pro |
| 20 | OSIR | Osiris Therapeutics | 234.34% | Go Pro |
| 21 | LGND | LIGAND PHARMACEUTICALS | 228.17% | Go Pro |
| 22 | DNDN | Dendreon Corporation | 217.95% | Go Pro |
| 23 | ADK | Adcare Health Systems | 207.90% | Go Pro |
| 24 | SPPI | Spectrum Pharmaceuticals | 204.89% | Go Pro |
| 25 | PGNX | Progenics Pharmaceuticals | 195.07% | Go Pro |
| 26 | VRX | Valeant Pharmaceuticals International | 188.37% | Go Pro |
| 27 | ALKS | Alkermes | 185.71% | Go Pro |
| 28 | OREX | Orexigen Therapeutics | 178.25% | Go Pro |
| 29 | SVNT | Savient Pharmaceuticals | 161.23% | Go Pro |
| 30 | EXEL | Exelixis | 128.82% | Go Pro |
| 31 | PTX | Pernix Therapeutics | 120.10% | Go Pro |
| 32 | BNVI | Bionovo | 119.12% | Go Pro |
| 33 | AMS | American Shared Hospital Services | 113.74% | Go Pro |
| 34 | BLTI | BioLase Technology | 109.98% | Go Pro |
| 35 | ZLCS | Zalicus | 108.23% | Go Pro |
| 36 | INO | Inovio Pharmaceuticals | 106.58% | Go Pro |
| 37 | GNMK | GenMark Diagnostics | 101.53% | Go Pro |
| 38 | ARAY | Accuray | 96.19% | Go Pro |
| 39 | SGNT | Sagent Pharmaceuticals | 94.09% | Go Pro |
| 40 | BSTC | Biospecifics Technologies | 91.36% | Go Pro |
| 41 | QCOR | Questcor Pharmaceuticals | 91.28% | Go Pro |
| 42 | CERS | Cerus Corporation | 85.31% | Go Pro |
| 43 | HS | HealthSpring | 83.57% | Go Pro |
| 44 | BGMD | BG Medicine | 82.65% | Go Pro |
| 45 | IMGN | ImmunoGen | 82.31% | Go Pro |
| 46 | SLXP | Salix Pharmaceuticals | 81.39% | Go Pro |
| 47 | BONE | Bacterin International | 79.87% | Go Pro |
| 48 | UTMD | Utah Medical Products | 73.84% | Go Pro |
| 49 | ALTH | Allos Therapeutics | 72.48% | Go Pro |
| 50 | CYAN | Cyanotech Corporation | 71.12% | Go Pro |